Vendor, San Francisco, CA
Agilemd, Inc.
UEI DE6UGMUW6LS4, CAGE 6FZM9
1 award and $0 obligated between June 25, 2024 and June 25, 2024, 100% under full and open competition, against 20.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 | $0 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 1 |
| Definitive Contract | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75A50121C00043Definitive Contract, June 25, 2024, Full and Open Competition, 20 offers | Barda - Aspr / Daappo / Barda DCMAOffice of Assistant Secretary for Preparedness and Response | EO14042 Agilemd - the Overall Objective of This Contract Is to Fast Track the Development and Deployment of Ecart, a Clinical Decision SuppoNAICS 541714, PSC 7A21 | $0 |
- Places of performance
- California
- Product and service codes
- 7A21 Business Application off-the-shelf software delivered by perpetual license, which also encompasses enterprise level software enabling mission capability and business operational support.
- Transactions
- 1 across 1 awards